Speaker 1 [00:00:07] Steve, good to see you again, friend. It was good to see you in person just a couple of weeks ago in Orlando.
Speaker 2 [00:00:13] Yeah, And time has flown fast already since I saw a lot of happened in the world since then. Yeah. And great to be back again.
Speaker 1 [00:00:19] Yeah. Yeah, I. I know that you and I and Tom are going to have a SARS wrap up, but one of the things that struck me while we were there and when I was reviewing a lot of the the sets that we did while while in Orlando was the nationalist mindset that seemed to occur. You know, you were talking about it was a Chinese robot, it was a French robot, it was an Italian robot. It’s a Spanish robots, a U.S. robot. And so. You know, to sit back there and go, how is that nationalist mindset? And let’s assume that they all want to come to the U.S. because that’s where they want to come. Biggest market there is, so to speak. How does that mindset seem to affect success or lack of success in a U.S. market from your perspective?
Speaker 2 [00:01:10] Yeah. So I think one of the it’s just a there’s a couple of problems that happens, especially a lot of these robots that come out of things like university settings. And we’ve discussed this before. They’re not understanding what the real commercial world is and they don’t understand what it means to try and get into the U.S.. The lift, the size, scale, the importance of the market and also the severity of the market. You know, you can’t make too many mistakes, so you don’t get many bites of the cherry when you come into the U. That’s you know, they’ll they’ll tell you pretty quickly if your system is good enough or not good enough. So I think one of the problems is that a lot of the nationalistic companies have their own paradigm fairly well sorted for their own country, but then they just get this huge shock when they then come to the U.S. That’s one of the problems.
Speaker 1 [00:01:59] The and that’s really interesting because as I’ve built these teams, you know, you and your career have been on early stage of course. But then that that commercial lift is always underestimated because people start at the engineering level and say, we’ve got a robot, let’s look for the problem versus where’s the market? Let’s build a robot to address that market, that workflow, that team, that mindset, that reimbursement, etc.. So but one of the things I’ve seen in my role is I’ve built all of these tech companies and health tech and especially the robotics companies is, you’re right, it comes out of a university, generally speaking, and that universities starts to get this inertia going. And then eventually once you get past that around into the B round, you’re now starting to say, well, let’s start, let’s start looking at the market. These university level engineers and even maybe device engineers are still running the show and they’re disconnected from the US market, right? The workflow, the team. ET cetera and everything down to drapes, selection and draping a robot which is then becomes a pain in the ass in the workflow in that setting of care. Then what happens? Somebody gets a bright idea. Usually the investors and they say, Hey, we need somebody in the US. And while the US is there, the communication styles between countries outside the US are always different, even between the UK and the US. The nuance, they’re like, I’ve got a Jersey client, I mean a UK client who has a team in New Jersey. It’s not a robotic company, but it’s a complex system and the communication between those, you would think same language, same culture. You guys birthed us. The friction there, the passive aggressiveness between those two, the teams, the R&D teams is just insane. And then, you know, do that with Israel or do that with France or do that with Italy. And so you get this built in friction that burns through calories, money and time that also is underappreciated.
Speaker 2 [00:04:03] Yeah. And it’s a it’s an accumulation of micro differences. This is the thing. It’s a little bit the language, it’s a little bit the way that you approach things. It’s a little bit the way that engineers approach. You know, engineers in France definitely approach things different than I’ve seen engineers in California. There’s an attitude difference. And then there’s a knowledge gap that happens where in my mind, there’s way too many assumptions made from both sides. And especially when you come out of, say, a Europe or even it’s going to be coming out of China, the knowledge gap between what you actually have to deliver and what you think in your head, you have to deliver in terms of functionality, in terms of service, in terms of the way you deliver your commercial model. All those things start stacking up and that’s why you see these, you know, sudden car crashes of problems. It’s never one individual thing. It’s an accumulation. It’s like death by a thousand paper cuts is the way that I say it. And. And you? Why? Often the problem with things like a surgical robot is when you get down that path. It’s not like tomorrow you wake up and say, I think we got it wrong. Let’s just flip and change. That’s the problem. That’s a really big problem.
Speaker 1 [00:05:24] And that that’s the point right there. And whether it’s even a US developed robot that is addressing the US is what you sort of meant. That platform, that system, that commitment to a level. I mean, let’s look at and I don’t want to make it the punching bag in the room. Let’s look at a Yugo where that that form factor was established 12, 14 years ago and you couldn’t move off that construct or you could have. But leadership said, we’ve got way too much money and let’s keep on putting money on it. Right. And you and then as you make these assumptions. And if the assumptions are off as you go down range with time, they become really off. And so to your point, you’ve got cultural differences, you’ve got engineering differences, you’ve got marketing differences. You’re 80% baked. You think when you’re coming from a U.S. to the U.S., you get here, you say, okay, we’ll figure it out once we get there. Well, we’ll maybe hire a U.S. person to help lead that effort for us. But the system that the delivering the care is the fault.
Speaker 2 [00:06:36] Yeah, and that’s that. I’ve seen that firsthand. You think to yourself, well, the U.S. team will just work it out for us. And I think on a very low, basic, simple product, I’m sure on a commodity product, there’s something they can do. I mean, they can’t they can’t fix the workflow, right? You can’t hire a good US VP of Sales who suddenly fix the workflow because you’re kind of locked into it. You’re locked into it the way you do the FDA. The FDA often tells you how the workflow is going to work as well. And then the other the other problem I definitely see is that and I can speak as a European, why often we see the USA as a big homogenous lump and we think that San Diego is the same as Boston is the same as Houston is the same as Miami. And you as a U.S. would just look at me and say, you’re absolutely bonkers. That’s like saying Europe is all the same. I think it’s just desperate and sometimes even more desperate in the U.S. when I look across it. So that is a problem that people get into, is they come to the U.S. when really they should be coming to a group of states and understand each state as well. I think I think that’s a generic problem that you get from the U.S. team coming to U.S..
Speaker 1 [00:07:47] Yeah. And then you get on top of that. And that’s a great point. You know, I’ve lived in the U.S. my whole life and I’m in a New Yorker, so I kind of speak a different dialect. But there are times when I’m chatting with somebody who’s from the Deep South. And it I’ve got to really sit there and concentrate if I’m only hearing them on the phone and I can’t actually speak to them, you know, in person. And so you compound that if you’re coming from o U.S., you say, well, these are the words they said. But then the health care systems change from region to region and even state to state as well, which then will drive your reimbursement, which will then impact your financial model, and then your sites of care will change. I’ve got a friend who runs a really successful ASC on the author side down in Houston. He gets paid $1,500 for a joint replacement. The hospital down the block gets $4,500 for the joint replacement. So how do you model that if you’re even if you’re a U.S. company, that’s a challenge. But when you’re a no use company, and I’ve brought so many U.S. companies to the U.S., they are just not even aware that those struggles are here.
Speaker 2 [00:08:52] Yeah. And so. So you see that as well more when it’s, for example, UK based companies because they make the presumption that we speak the same language. Okay. That’s the first presumption that they make. So, you know, how how much more difficult and how much more different can it be? And then they get really surprised when they walk in and realize. The other thing that I see is that. And I’ve actually been involved with a lot of companies where they say, well, we’re going to go to the U.S.. But they don’t realize that for different products you need a very different entry strategy into the U.S. in a different location. There’s certain places that, for example, are better known for taking on innovation than other places that are really, you know, stalwart die hards who, you know, they don’t want to change, won’t name which ones they are. But but there are different even by states or by parts of states where I’ve seen the technological adoption is just much easier as a mentality by the surgeons and by the by the hospital administration to take on new challenges, new exciting things. So there’s more like oddly, in the way that they approach it and all these nuances, you can screw up really badly for us because you only get one bite at the cherry. This is the other thing that I try and tell to people. Spend 80% of your time planning, making sure and verifying it, getting it right. Because if you go in, it’s very rare that you go in and have a disaster and survive. You know, it’s it’s a pretty brutal market compared to many others. So I do try and when I when I advise people when they go into the U.S. to really understand is your product fit for purpose for the U.S. market and is it fit for purpose for multiple states? And of those states, which one should you go to first and where should you put your beachhead? It’s not a country. It’s a continent. It’s massive. And I’ve seen people say, yeah, we’ll put a logistics center down in Orlando. Yeah, in Asia Logistics Center in Orlando. And they think they’re going to run the entire business across the U.S. of it. So so these are just the misunderstandings that create these problems. And unfortunately for medical devices, especially in a coin operated system, which much of the U.S. is, you don’t get to chances are news travels fast.
Speaker 1 [00:11:18] Really fast. And then I want to I want to say, okay, so we identify the challenges then what could potential solutions be? And then there’s one more I want to throw on top of the pile. The number of times a client will come to me and say, We tried to hire ourselves in the U.S. talent and we got it wrong. We hired this one person and all they did was collect the paycheck for six months and we didn’t realize what they were doing, and they tell me who the person was as well. That wasn’t going to be hard for me to figure that out because they’ve been running that shell game their whole career. Yeah, but they came out of robotics and like, you know, if that was your qualifier, you know, you, you don’t know how to check that lineage of that person and their performance. So, so you compound that and people say, Yeah, don’t worry, I know how to launch that. I know how to take that through. And they get taken a large percentage of the time. And if you go to launch a robot, you’re going to need 6 to 8, conservatively speaking, clinical people there to help surprise, delight and help get into the you know, whether you’re going to VP or you’re going to something, you’re going to somebody else. You’ve got to get that right and then you’ve got to get that leadership right. Who’s going to lead them? And then you’ve got to make sure they don’t have a poor name, because as soon as they walk into that O.R. suite or teaching university, they’ve got a reputation. And then you start and and they’re going to they’re going to cloak that from you as long as they can and collect that paycheck. It’s just human nature. And then all of a sudden, you’re going to drop hundreds of thousands of dollars per month. And you’re going to burn through to your point. You don’t get to make a U-turn on a surgical robot. Okay, So you and I have done the easy thing. We’ve identified why these things happen. Maybe not so easy because we still see these venture groups and startups make the same mistakes in the same playbook coming to the U.S.. What what would be the guidance we give to these organizations? And let’s I’m going to I’m going to be a little provocative shocker. How about the ones that are just ready to start come to the US right now. So let’s go like an SS innovation, right? They’re cooked. They’ve got a great reputation. They’re about ready to come to the U.S. What should they be doing if they were sitting on the other side of the table with you?
Speaker 2 [00:13:33] Yes. So I think I think there’s several things that you can do to minimize risk. You can never eliminate it. Right. You don’t notice that the rubber hits the road. And again, if there’s inherently things wrong in your system that don’t fit the U.S. workflow, that’s going to be hard to overcome. Well, let’s say that the robot can work. I think one of the main things for me is having, you know, building the right team, having the right competencies with the people who genuinely know what they’re doing. And to do that, to your point. As people like yourselves who know who will be the successful people and not just, you know, it was really good interview, which I think is really important. And you need to you need to build up leadership out way ahead, way ahead of the game. I’m talking a long time ahead of the game. They need 18 months to gain momentum on a surgical robot. I think what you’ve also then got to do is you’ve got to really decide, you know, one of the most important things. Where are you going to put your office? Where is that going to sit and why? What’s the office going to be in me? How is the whole logistics going to work? And these things take 12 months to really work out. There are there are good services that will help you to get good data. And there is one thing about the U.S. that is different than a lot of Europe is. There is very good data out there. So if you’ve got a robot that really kicks in gynecology and a CS, you can get that data and understand where those centers are, where that mass of patients are. So at least you’re trying to build your business in the right place. Like you don’t want to out in the middle of Nebraska, maybe if that’s not the place where you know the action is happening. But it just it just so happens to be where the VP of sales that you hired lives people. So so I think I think and you have to come at it with a cleaning slate as well. You can’t take what you’ve learned in your remote and automatically transfer it. And I think that goes across across the whole thing. You know, the good clinical experts that you have in the O.R. in Germany. Might not be the exact same profile that you’ll want for Florida. So I think there’s you’ve got you’ve got to go and get a really strong leadership team. Via an organization like yourselves that can build that team so that you actually get good decision points made and then sort of. Sullivan Go on here. But the final piece on this is then don’t then dictate to them. You’ve got to let them run with it.
Speaker 1 [00:16:08] That, that right there is golden and probably underappreciated because. If you’re going to hire somebody to build that team, you cannot have them pull punches. And you’re better off spending a lot more time and your diligence of hiring that person. And letting them run and certainly report back, but letting them run and run hard. And here’s the one that’s always difficult when you come to the U.S.. The compensation packages are astronomical compared to any other country in the world. And so the number of times I have to upfront when I’m writing a chief commercial officer role or even a go to market role and. They come in with the lowball number. And I said, you can get somebody at that number, not anybody you’d actually hire for real based on the spec. So you’ve got to come in and you probably want to tremendously increase your budget that you originally planned three years ago because you had no sense of the market. And the market numbers are continuing to be driven up because now these robots are coming here and the good players justifiably are getting good comp packages coming in. So that that is really important is pick the right person. Overpay them because you’ll underpay them. Net net at the end and let them run the game plan. That’s, I think, critical.
Speaker 2 [00:17:37] I think there’s nothing frustrates people more than being hired in and then micromanaged. I think that’s that’s just I’ve seen that time and time again and again. That’s a little bit of a cultural thing as well. In the U.S., you know, you’ve got a lot of people, especially the kind of people we want to hire into these companies are entrepreneurial in terms of their thinking and everything. You can’t micromanage them then down to do that. And the second piece of that there is on the micromanagement is. One thing I will say to everybody is set yourself up a very well clear and structured governance system. Because you need to know who is responsible for what, who is doing what, what they can and can’t sign off, etc.. And you’ve got to get that really clear up front because again, there is an ocean. If you come out Europe, as you know, this notion that way coming out of Asia, this notion the other way and that that goes for time and distance actually makes a really important problem and confusion. So you have to be super clear up front. This is the governance. This is the decisions you can make. This is the decisions you can’t make and let people really understand that and then let them do the decisions. What you can’t do is give them given the authority and then undermine them and kick the legs out from under them every time that they do it, because that’s just not going to work either.
Speaker 1 [00:19:01] And that’s a really great point, Steve. The governance and here’s the guidelines of of things you can because otherwise it gets back bounced back and forth between the organizations delayed. You’re burning through cash every day that that gets delayed it gets compounded. And maybe even more importantly, the esprit de corps. Of the organization. Absolutely. Once you lose that and it gets suffocated, you can’t resurrect it. And then as the. As the. Original host country. We’re not the host country, but the country where it was idea that we’re quote unquote leadership now is you find out way too late and you’ll turn around and you’ve burned through tens of millions. So that’s that’s great insight that I hadn’t really thought through. I’ve experienced it all the time in building these US teams that are coming to the US. So that’s that’s fascinating. So let’s just before we close up, who are you keeping your eyes on coming out of some of these countries? So out of Japan, who are you keeping your eyes on right now in regards to systems?
Speaker 2 [00:20:06] Yes, it’s the medical void in a Tory system, which. I think he’s actually a very good system. They’ve got they’ve got a couple of features in that. It’s very the Vinci like, but it’s not Da Vinci like in other ways. And I think that’s interesting because I said this in one of my podcasts. It’s that quality is superb. And at the minute that’s what’s hindering and hampering a lot of the robot companies is that quality and reliability that with Kawasaki heritage is just pretty great. So yeah, I think in Italy, what can they culturally that you talk about culture shift, right? Can you take the Japanese culture shift and can you now bring that even into Europe this, you know, mind the US, but how do you break that? It all has to be thought and debated in Japan and decided in Japan by the senior management in Japan. If they can’t break that, I think they’ll struggle. Yeah, I think a struggle, but it’s as a system I think it’s I think it’s amazing quality.
Speaker 1 [00:21:01] How about India coming out of India? What are you watching out of there?
Speaker 2 [00:21:04] Yeah. So, you know, I’ve actually had a chance to go on the assignment for three, you know. Think it’s good. I think for for certain markets it’s going to be really acceptable if they do get their promise of one third. The cost I don’t mean the price, the robot, one third of the cost per procedures and things, then I think that will be interesting. The big thing that they have that nobody else is really pushing the moon is the cardiac. And they’ve got lots of innovation going in cardiac. My one pleads that team was just watch the quality the which like the opposite of the Japanese thing it’s you know you can’t see blue green and red wires at the back of a robot while you’re using a robot in certain markets like Europe and the U.S. But I think their innovation is goodness speed’s good. And I think that’s an interesting one to watch.
Speaker 1 [00:21:50] South Korea.
Speaker 2 [00:21:52] Yeah, it’s so interesting, Lee. You know, Evil Eye has been on my radar for a long time and they sort of pick it up. So it went through a dip and they seem to be picking up again now. So I think this sorted out some of their quality problems. But I you know, Lives Med is an interesting company as well. So the handheld instruments, their instruments are very good. I think they may go to do some kind of joint venture somewhere and get their instruments on a robot that’s struggling with their instruments. I think that could be very interesting.
Speaker 1 [00:22:24] And there was a player at SARS coming out of Spain, Rob Surgical, and they they made a bit of noise.
Speaker 2 [00:22:31] Yeah. And that was interesting cause I’d sort of written off in my head. It just didn’t even register with me at all. Was anything that good. And then I went to see it and I actually, I was actually more impressed with it than I thought. It’s still, you know, it’s a big boom robot with a different architecture. They’ve got some really clever things in there. Like they’ve, you know, they’ve made it. So we talked a lot about, you know, how open is your system to having other people’s imaging systems where you can put anybody’s imaging system on it? I think that’s smart because they’re not imaging experts. They’re robo experts. So that’s another really good one that I think I think is want to watch.
Speaker 1 [00:23:09] And then finally, the the. Brain trust of watch movement. Switzerland.
Speaker 2 [00:23:18] Yes. Yeah. So obviously you’ve got a distal motion coming out of there. And you know, I spoke with Greg a while back and I was very pleased to hear when when I asked Greg, you know, are you trying to go in the wild everywhere? And he was actually very reserved on that and said, you know, we’re going to go with a very focused approach. And again, I’ve lived it myself and I’ve seen how you do it right. And I’ll maybe go to Wild too, too fast. I think if they can do a couple of things. One is stick true and not get their investors push them to just put push, push, push, get it really focused and improve their thesis, which is not the same as most robots. It’s not the same as a moon, not the same as Da Vinci. They’ve got to prove out their thesis and show that it works. I think that they’ll do well. And the second thing that they’ve got to work on a little bit is, you know, there’s a little bit of feedback on the control mechanism, the software control mechanism and the instruments, again, which is going to be the Achilles heel of most companies. But I think if they can fix that, the idea of being able to scrub in at a table and switch between actually has a lot of intrigue for many, many surgeons across the world.
Speaker 1 [00:24:34] Well, as usual, I really enjoy our conversations. I think we I think you said it yesterday and one of the link then you and I tend to talk about the things that most people won’t because we don’t have anything to protect. Actually, we have things to discuss and ask people at least to think about. And I always appreciate your insights into things, Steve.
Speaker 2 [00:24:55] No, thanks very much. And again, I mean. I think both was at the same thing at heart, which is we want the tide to take all boats up. And, you know, sometimes if you if you shy away from the reality and the truth, don’t say it is a lot of managers can sit there in a false sense of security. We can say and we can be wrong. Right. We can always be wrong. But at least it it said they can think about it and chew on it and their teams can think about it. And if that triggers something where somebody does something a little bit better than I think we’ve done our job.
Speaker 1 [00:25:25] I agree. I agree. Well, enjoy the the heat wave there. I understand it’s a warm one. So you’re in Florida weather only. We’re used to it.
Speaker 2 [00:25:36] Joe. Thanks very much, Joe.
Speaker 1 [00:25:37] Take care. You got to be well. I’m Joe Mullings from 160 Studios. Be well.